Who's buying Iambic Therapeutics, Inc.?

IAM insider buying, 13F and 13D filings

• Oct 19, 2026Insider buy
  Evan Lockwood Rachlin (Director): Bought $11.5M on the open market
  718.8K shares at ~$16.00, traded 2026-10-16. Now holds 2.59M shares (stake up 38%).
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.